Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07512570

Feasibility and Preliminary Effects of a Structured Resistance Training Program in Children Aged 10-14 Years

Feasibility and Preliminary Effects of a Structured Resistance Training Programme in Children Aged 10-14 Years: A Randomised Controlled Pilot Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
31 (estimated)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
10 Years – 14 Years
Healthy volunteers
Accepted

Summary

This study is a randomised controlled pilot trial designed to evaluate the feasibility, safety, and preliminary efficacy of a 12-week resistance training intervention in children aged 10-14 years. The study adheres to the CONSORT extension for randomised pilot and feasibility trials and incorporates key elements of the SPIRIT guidelines for clinical trial protocols. The primary purpose of the study is to assess feasibility-related outcomes and to generate effect size estimates to inform the design of a subsequent fully powered randomised controlled trial (RCT).

Conditions

Interventions

TypeNameDescription
BEHAVIORALProgressive Resistance Training ProgramAn 8-week supervised progressive resistance training (PRT) program performed twice weekly in children aged 10-14 years. Each \~45-minute session includes a warm-up, whole-body resistance exercises (with emphasis on lower-limb musculature), and a cool-down. Exercises include squat variations, hip hinge movements, unilateral lower-limb exercises, upper-body pushing and pulling, and core stabilization. Training intensity is prescribed using a youth-specific rating of perceived exertion (RPE 5-8), with progressive overload applied individually based on proper technique. The program is divided into three phases: familiarisation (weeks 1-2), progressive overload (weeks 3-5), and strength-oriented training (weeks 6-8). Sessions are delivered in small groups under qualified supervision to ensure safety and adherence.

Timeline

Start date
2026-09-01
Primary completion
2027-12-31
Completion
2028-09-30
First posted
2026-04-06
Last updated
2026-04-06

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT07512570. Inclusion in this directory is not an endorsement.